Andros Pharmaceuticals

Andros Pharmaceuticals Co., Ltd. (Andros Pharma) is a biopharmaceutical company founded in 2008 and headquartered in Zhubei City, Hsinchu County, Taiwan. Founded by Dr. Ae-June Wang, who serves as President and CEO, the company specializes in developing novel drug delivery platform technologies with a focus on lipid encapsulation, liposomal formulations, and innovative topical dosage forms. Andros Pharma's core competency lies in advanced drug delivery systems that improve efficacy and safety of existing pharmaceutical compounds. The company achieved a landmark regulatory milestone with the first-ever new dosage form approval in Taiwan and holds a GMP/GDP license from the Taiwan FDA. Andros established an Australian subsidiary in 2017 and collaborates with international pharmaceutical partners. The company targets specialty pharmaceutical markets including dermatology and topical therapeutics, with a team of researchers spanning pharmacy, chemistry, chemical engineering, and molecular biology.